Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer [Phase 1]
This first-in-human Phase 1 study evaluates the safety of multiple dose levels of AGS-16M8F in patients with advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer [Phase 2]
Phase II study evaluating Aldesleukin (IL-2) after Zanolimumab in metastatic melanoma and metastatic renal cell carcinoma was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: LBH589 Treatment for Refractory Clear Cell Renal Carcinoma [Phase 2]
Phase 2 trial update for LBH589 in refractory clear cell renal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC [Phase 2]
Phase II trial of BAY73-4506 in previously untreated metastatic or unresectable renal cell carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Study In Patients With Kidney Cancer Treated With Sutent
A completed clinical trial evaluated Sutent (sunitinib) in patients with advanced or metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer [Phase 2]
Phase 2 trial S0312 evaluating gemcitabine plus capecitabine in patients with advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma [Phase 3]
A Phase 3 trial evaluating interferon plus temsirolimus (CCI-779) in advanced renal cell carcinoma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer [Phase 1]
A Phase 1 trial of Interleukin-7 in patients with metastatic melanoma or renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer [Phase 2]
Phase 2 study evaluating tariquidar with docetaxel in patients with lung cancer, ovarian cancer, cervical cancer, and renal cell carcinoma. …
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Vaccine Treatment of Kidney Cancer [Phase 2]
A Phase 2 clinical trial of a kidney cancer vaccine sponsored by the National Cancer Institute was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating early administration of anti-thymocyte globulin (ATG) followed by cyclophosphamide, busulfan and fludarabine as a c…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 [Phase 2]
Phase II trial update of a B7-1 gene-modified autologous tumor cell vaccine with systemic IL-2 in renal cell carcinoma; the study status is …
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer [Phase 3]
A Phase 3 trial evaluating medroxyprogesterone, interferon, and/or aldesleukin for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer [Phase 3]
This document provides an update on a Phase 3 trial evaluating interleukin-2 and interferon for metastatic kidney cancer.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer [Phase 3]
Phase 3 trial evaluating Interleukin-2, Interferon alfa, and Fluorouracil versus observation after surgery for kidney cancer; the trial stat…
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain [Phase 2]
A Phase 2 clinical trial evaluating conformal radiation therapy for metastatic cancers outside the brain was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer [Phase 3]
Agenus Inc. reports that its Phase 3 trial of a personalized cancer vaccine for non-metastatic kidney cancer (NCT00126178) has been terminat…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer [Phase 3]
A Phase 3 survival study evaluating Oncophage versus observation in patients with renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial comparing routes of administration of the personalized cancer vaccine Oncophage (HSPPC-96) in metastatic renal cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma [Phase 2]
A Phase 2 study of cediranib in metastatic or recurrent renal cell carcinoma has completed, with results posted in 2012.
-
FDA approval · 2012-08-29FDA Approved: AFINITOR DISPERZ — Original Application (Novartis Pharmaceuticals Corporation)
FDA approves AFINITOR DISPERZ (everolimus) under an Original Application for a dispersible tablet formulation.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]
Phase II, multi-histology trial of fostamatinib disodium (R935788) in advanced colorectal, non-small cell lung, head and neck, hepatocellula…
-
FDA approval · 2012-08-24FDA Approved: NEXAVAR — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Nexavar (sorafenib) submitted by Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer [Phase 3]
Phase 3 study comparing Pazopanib to Sunitinib in advanced or metastatic renal cell carcinoma completed with results posted in 2012, focusin…